EPIX: ESSA Pharma Inc Price to Sales

Symbol and logo of brand essapharma.com (EPIX)

ESSA Pharma Inc. (EPIX) is investing in the development of unique N-terminal domain inhibitors to combat hormonal tumors. The company's rolling P/S ratio reflects the dynamics of market capitalization relative to revenue, with the indicator currently standing at . Management is focusing on therapies for resistant forms of prostate cancer, and the current stage of clinical trials confirms the high potential of the product pipeline.

ESSA Pharma Inc (EPIX): Price-to-Revenue Ratio from 07/04/2022 to 11/13/2026

ESSA Pharma Inc. (EPIX) - metric breakdowns and financial figures

- stock price and consensus target price:
Share Price essapharma.com|EPIX - Analyst Consensus Forecast
- market capitalization information:
Market Value ESSA Pharma Inc|EPIX - Total Company Value
- shareholders' equity book value data:
Net Assets per Share ESSA Pharma|EPIX - Company Book Value|Market Capitalization to Book Value essapharma.com|EPIX - Company Total Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital ESSA Pharma Inc.|EPIX - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital essapharma.com|EPIX - Company Debts|Debts to Book Capitalization Ratio ESSA Pharma Inc|EPIX - Company Long-Term Debts|Company Short-Term Loans and Borrowings ESSA Pharma|Quick Ratio essapharma.com
- net income and valuation ratios data:
EPIX - Company Net Income|Expected Net Income ESSA Pharma Inc.|EPIX - Price to Earnings Ratio|Projected Price to Earnings essapharma.com|EPIX - PEG Multiple|EV/EBITDA Multiple ESSA Pharma Inc|EPIX - Operating profit before deduction of amortization|Earnings per share for the trailing year ESSA Pharma|EPIX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months essapharma.com|EPIX - Earnings per share growth in current year|Projected earnings per share growth rate for next year ESSA Pharma Inc.
- total revenue and sales volume data:
EPIX - Revenue and Sales Volume|Company Future Sales Volume essapharma.com|EPIX - Market Cap to Revenue|Market Cap to Expected Sales Ratio ESSA Pharma Inc
Fundamental company analysis:ESSA Pharma, Inc. - EPIX
Signature product of ESSA Pharma

Investors seek a balance between asset value and actual business revenue. This ratio measures market capitalization relative to sales volume, identifying whether a company is overvalued or undervalued. For ESSA Pharma Inc. (EPIX), this calculation reflects the monetization efficiency of ethical cancer therapy developments and adherence to ESG standards. The P/S ratio trend allows for tracking price sensitivity to financial results between reporting periods.

Competing companies

merus.nl - Market Cap to Revenue Ratio|P/S Multiple IMMP (Immutep)|Anixa Biosciences (ANIX) - Price to Sales|ATOS - Price-to-Revenue Ratio|Price-to-Revenue Coefficient Context Therapeutics CNTX|mersana.com (MRSN) - Price-to-Revenue Ratio|BCTX - Price-to-Revenue Coefficient|QTI (QT Imaging) - P/S Multiple